Cipla Ltd.
| BSE: 500087 | Sector: Health care |
| NSE: CIPLA | ISIN Code: INE059A01026 |
| BSE 00:00 | 18 Aug | 1032.10 |
6.60 (0.64%) |
OPEN
1026.25 |
HIGH
1033.55 |
LOW
1007.00 |
| NSE 00:00 | 18 Aug | 1032.20 |
6.45 (0.63%) |
OPEN
1028.50 |
HIGH
1034.05 |
LOW
1007.35 |
| OPEN | 1026.25 |
| PREVIOUS CLOSE | 1025.50 |
| VOLUME | 29688 |
| 52-Week high | 1083.15 |
| 52-Week low | 850.00 |
| P/E | 28.47 |
| Mkt Cap.(Rs cr) | 83,290 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Cipla Ltd. (CIPLA) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Sun Pharma.Inds. | 915.75 | -4.70 | -0.51 | 15585.98 |
| Dr Reddy's Labs | 4225.55 | -94.05 | -2.18 | 14405.20 |
| Cipla | 1032.10 | 6.60 | 0.64 | 13091.79 |
| Lupin | 688.50 | 0.95 | 0.14 | 11771.67 |
| Aurobindo Pharma | 582.95 | 2.55 | 0.44 | 11287.14 |
| Divi's Lab. | 3744.40 | -5.05 | -0.13 | 8879.82 |
| Alkem Lab | 2927.55 | -12.40 | -0.42 | 8829.81 |
| Zydus Lifesci. | 394.10 | -5.65 | -1.41 | 7981.90 |
| Glenmark Pharma. | 399.60 | -3.75 | -0.93 | 7567.93 |
| Torrent Pharma. | 1560.25 | 3.05 | 0.20 | 6742.32 |
| Apollo Hospitals | 4270.55 | -30.30 | -0.70 | 6098.30 |
| Ipca Labs. | 925.00 | 4.65 | 0.51 | 5399.36 |
| Alembic Pharma | 654.70 | -1.95 | -0.30 | 5051.44 |
| Abbott India | 19012.00 | -188.15 | -0.98 | 4919.27 |
| Laurus Labs | 590.25 | -1.20 | -0.20 | 4707.04 |
| Gland Pharma | 2399.10 | 29.35 | 1.24 | 4400.71 |
| Granules India | 325.25 | -1.70 | -0.52 | 3238.44 |
| Glaxosmi. Pharma | 1478.60 | 16.35 | 1.12 | 3217.51 |
| Ajanta Pharma | 1258.65 | -15.30 | -1.20 | 3140.64 |
| Sanofi India | 6375.00 | -33.40 | -0.52 | 2956.60 |
Quick Links for Cipla:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
